Patent details

EP3828173 Title: SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS

Basic Information

Publication number:
EP3828173
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP201917473
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS
French Title of Invention:
PYRAZOLES SUBSTITUÉS EN TANT QU`INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE HUMAINE
German Title of Invention:
SUBSTITUIERTE PYRAZOLE ALS MENSCHLICHE PLASMAKALLIKREINHEMMER
SPC Number:

Dates

Filing date:
09/03/2015
Grant date:
31/08/2022
EP Publication Date:
02/06/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/08/2022
EP B1 Publication Date:
31/08/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/08/2022
 
 

Name:
BioCryst Pharmaceuticals, Inc.
Address:
4505 Emperor Blvd., Durham, NC 27703, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
18/11/2022
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
ZHANG, Weihe
Address:
United States (US)

2

Name:
KOTIAN, Pravin L.
Address:
United States (US)

3

Name:
WU, Minwan
Address:
United States (US)

4

Name:
CHINTAREDDY, Venkat R
Address:
United States (US)

5

Name:
KUMAR, Satish V
Address:
United States (US)

6

Name:
BABU, Yarlagadda S.
Address:
United States (US)

Priority

1

Priority Number:
201461949808 P
Priority Date:
07/03/2014
Priority Country:
United States (US)

2

Priority Number:
201461981515 P
Priority Date:
18/04/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07D 231/14; A61K 31/415;

Publication

European Patent Bulletin

1

Issue number:
202235
Publication date:
31/08/2022
Description:
Grant (B1)

2

Issue number:
202238
Publication date:
21/09/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
20/03/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
SUN IP LLC
Filing date Document type Number of pages
18/11/2022 Power Of Attorney 2
18/11/2022 Outgoing Correspondence 1